Isospaglumic acid

DB19650InvestigationalSmall molecule

Isospaglumic acid is a small molecule drug. Isospaglumic acid is under investigation in clinical trial NCT06800274 (Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With... Isospaglumic acid has a monoisotopic molecular weight of 304.09 Da.

Chemical structure of Isospaglumic acid
Formula / weight
C11H16N2O8 · 304.255 g/mol (avg)
Code names
ZY-15106

Resolves to

Compound
UNII1W8M12WXYLCAS3106-85-2ChEMBLCHEMBL1329032ChEBI73688
Clinical / RWD
RxNorm236303
Structure
InChIKeyOPVPGKGADVGKTG-BQBZGAKWSA-NSMILESCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O
Targets
Q14832GRM3

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Isospaglumic acid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In